Literature
首页医源资料库在线期刊美国临床营养学杂志2006年84卷第5期

Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Weightloss,throughcalorierestrictionorincreasesinenergyexpenditureviaexercise,improvesglucosetoleranceandinsulinaction。However,exercise-inducedenergyexpendituremayfurtherimproveglucoregulationthroughmechanismsindependentofweightloss。Objective:......

点击显示 收起

Edward P Weiss, Susan B Racette, Dennis T Villareal, Luigi Fontana, Karen Steger-May, Kenneth B Schechtman, Samuel Klein, John O Holloszy and the Washington University School of Medicine CALERIE Group

1 From the Division of Geriatrics and Nutritional Sciences, Department of Internal Medicine (EPW, SBR, DTV, LF, SK, and JOH) and the Division of Biostatistics (KS-M and KBS),Washington University School of Medicine, St Louis, MO, and the Division of Food Science, Human Nutrition and Health, Istituto Superiore di Sanitá, Rome, Italy (LF)

2 Supported by NIH Cooperative Agreement AG20487, NIH General Clinical Research Center Grant RR00036, Diabetes Research Training Center Grant DK20579, and NIH Clinical Nutrition Research Unit Grant DK56341. EPW was supported by Institutional National Research Service Award NIH AG00078.

3 Address reprint requests to JO Holloszy, Campus Box 8113, 4566 Scott Avenue, Washington University School of Medicine, St Louis, MO 63110. E-mail: jhollosz{at}im.wustl.edu.


ABSTRACT  
Background: Weight loss, through calorie restriction or increases in energy expenditure via exercise, improves glucose tolerance and insulin action. However, exercise-induced energy expenditure may further improve glucoregulation through mechanisms independent of weight loss.

Objective: The objective was to assess the hypothesis that weight loss through exercise-induced energy expenditure improves glucoregulation and circulating factors involved in insulin action to a greater extent than does similar weight loss through calorie restriction.

Design: Sedentary men and women aged 50–60 y with a body mass index (kg/m2) of 23.5–29.9 were randomly assigned to 1 of 2 weight-loss interventions [12 mo of exercise training (EX group; n = 18) or calorie restriction (CR group; n = 18)] or to a healthy lifestyle (HL) control group (n = 10). The insulin sensitivity index and areas under the curve for glucose and insulin were assessed with an oral-glucose-tolerance test. Adiponectin and tumor necrosis factor concentrations were measured in fasting serum. Fat mass was measured by dual-energy X-ray absorptiometry.

Results: Yearlong energy deficits were not significantly different between the EX and CR groups, as evidenced by body weight and fat mass changes. The insulin sensitivity index increased and the glucose and insulin areas under the curve decreased in the EX and CR groups, remained unchanged in the HL group, and did not differ significantly between the EX and CR groups. Marginally significant increases in adiponectin and decreases in the ratio of tumor necrosis factor to adiponectin occurred in the EX and CR groups but not in the HL group.

Conclusions: Weight loss induced by exercise training or calorie restriction improves glucose tolerance and insulin action in nonobese, healthy, middle-aged men and women. However, it does not appear that exercise training–induced weight loss results in greater improvements than those that result from calorie restriction alone.

Key Words: Aging • calorie restriction • exercise training • glucose tolerance • weight loss • overweight humans


INTRODUCTION  
Reductions in body weight and abdominal fat, induced by calorie restriction or by increasing exercise energy expenditure, improve insulin action and glucose tolerance (1), which are often impaired in overweight and obese persons (2, 3). In addition to weight loss induced by an energy deficit, exercise induces increases in muscle insulin sensitivity and responsiveness that are independent of weight loss (4). Previous studies have compared the effects of exercise training with those of calorie restriction on weight loss; however, exercise training in these studies was accompanied by an increase in energy intake such that little or no weight loss occurred (5-7). Although these studies provide information about the weight-loss–independent benefits of exercise training, they may understate the beneficial effects of exercise training because exercise training in the absence of changes in energy intake results in weight loss (8, 9). The purpose of the present study was to test the hypothesis that exercise training–induced weight loss results in greater improvements in glucose tolerance and insulin action than does similar weight loss induced by calorie restriction. We also assessed changes in circulating glucoregulatory factors [ie, adiponectin, tumor necrosis factor (TNF-), cortisol, and free fatty acids (FFAs)] that might contribute to changes in insulin action to gain preliminary insights regarding the mechanisms for improvements in glucoregulation induced by exercise training or calorie restriction. The data reported in this article were obtained as part of an investigation (CALERIE—Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) of the feasibility of long-term calorie restriction on potential markers of aging and risk factors for age-related diseases.


SUBJECTS AND METHODS  
Participants
Men and women aged 50–60 y with a body mass index (BMI; in kg/m2) of 23.5–29.9 were recruited from the St Louis metropolitan area. After screening and before baseline testing, the participants were randomly assigned (stratified by sex) to 1 of 2 weight-loss interventions [12 mo of exercise energy expenditure (EX group; n = 18) or calorie restriction (CR group; n = 18)] or to a healthy lifestyle (HL) control group (n = 10). Although the selection criterion included the high end of the range for normal BMI, only 9 enrolled subjects (5 in the EX group and 4 in the CR group) had a BMI < 25.0. Candidates for the study were excluded if they had a history of diabetes or a fasting blood glucose value 126 mg/dL; a history or clinical evidence of coronary artery disease, stroke, or lung disease; a resting blood pressure 170 mm Hg (systolic) or 100 mm Hg (diastolic); or a recent history or evidence of malignancy. Furthermore, all candidates had to be nonsmokers, had to be sedentary (defined as exercising <20 min/d, twice per week, during the 6 mo before baseline testing), and had to not be taking medications that could affect study outcomes. The women had to be postmenopausal. All participants gave their informed written consent to participate in the study, which was approved by the Human Studies Committee and the General Clinical Research Center Advisory Committee at the Washington University School of Medicine.

Calorie restriction intervention
The objective of the calorie restriction intervention was to decrease calorie intake by 16% during the first 3 mo and by 20% during the remaining 9 mo. The initial calorie intake was assumed to be equal to total daily energy expenditure (TEE) as determined by the doubly labeled water (DLW) method over 2 consecutive 2-wk assessment periods. Calorie intake prescriptions were calculated as baseline TEE minus the desired magnitude of calorie restriction (ie, 16% or 20% of TEE). The participants met with the study dietitians weekly, at which time body weight was measured and consultation was provided to maximize compliance with the prescribed calorie restriction. The participants frequently recorded their food consumption. The dietitians used these records, qualitatively, as a basis for personalized dietary changes that would help the participants achieve the prescribed calorie restriction. The general strategy was to encourage reductions in portion size and to substitute foods with a low calorie density with those with a high calorie density.

Exercise training intervention
The goal of the exercise training intervention was to induce the same calorie deficit as was induced by the calorie restriction intervention by holding energy intake constant at baseline levels and increasing exercise energy expenditure by 16% of baseline TEE for the first 3 mo and by 20% for the subsequent 9 mo. Exercise energy expenditure goals were given to the participants during weekly meetings with exercise trainers. The participants exercised, either in our facility or on their own, while using wrist watch–type heart rate (HR) monitors (S610; Polar Electro Oy, Kempele, Finland) that stored exercise-specific data for gross energy expenditure, HR, exercise duration, and the number of exercise sessions performed. Maximal oxygen uptake (energy expenditure goal:

RESULTS  
Participants
Sample sizes for recruitment and for each stage and arm of the study are diagramed in Figure 1. Of the 48 participants who started the study, 2 dropped out before the follow-up OGTT and were therefore not included in the analyses for the present report. Sex and racial group representations were not different in the EX, CR, and HL groups: 67%, 61%, and 60% female, respectively (P = 0.92) and 89%, 94%, and 70% white, respectively (P = 0.32). Participants in the EX group were slightly older than those in the CR (P = 0.0006) and HL (P = 0.02) groups (59 ± 3, 55 ± 3, and 56 ± 3 y, respectively). Inclusion of age as a covariate in the outcome analyses did not affect the study findings (data not shown); therefore, age was not included as a covariate in the reported data.


View larger version (42K):
FIGURE 1.. Consort diagram indicating sample sizes at each stage and in each arm of the study.

 
Physical activity levels
Physical activity, as assessed with the 7-d PAR, increased from baseline during the intervention in the EX group and remained unchanged in the CR and HL groups (Figure 2). The interaction between group and time for physical activity levels was significant (P = 0.0497) after baseline physical activity levels were accounted for.


View larger version (20K):
FIGURE 2.. Mean (±SE) physical activities and energy intakes before and during the intervention for the healthy lifestyle (HL) control group (n = 10), the calorie restriction (CR) group (n = 18), and the exercise training (EX) group (n = 18). Physical activity was derived from a recall questionnaire. Baseline values were not significantly different between groups for any of the variables (ANOVA). Interactions between study group and time were significant for physical activity (P = 0.0497), energy intake measured by the doubly labeled water (DLW) method and dual-energy X-ray absorptiometry (DXA) (P = 0.01), and energy intake measured with a food diary (P = 0.003) by repeated-measures mixed-model ANOVAs that included baseline values as a covariate. *Significantly different from baseline, P 0.05 (repeated-measures mixed-model ANOVA and Tukey’s tests).

 
Exercise training volume and mode
According to HR monitor data, net exercise energy expenditure for participants in the EX group averaged 228 ± 131 kcal/d over the 12-mo intervention, and this was accomplished in 5.8 ± 2.5 exercise sessions per week at an average exercise duration of 62 ± 18 min per session. These estimates of exercise quantity are conservative because the participants did not record 13.5 ± 16.8% of the exercise sessions on the HR monitors according to the weekly questionnaires. Exercise intensity was 71 ± 9% of maximal HR measured during the most recent Aerobic capacity
Baseline O2max changed from baseline to 12 mo in the HL group (Table 1
View this table:
TABLE 1. Aerobic capacity before and after the intervention1

 
Energy intake
According to DLW-based estimates, energy intake during the intervention in the EX and HL groups was not significantly different from baseline (Figure 2). Energy intake in the CR group was significantly lower than baseline during months 0–9. During the last 3 mo of the study, energy intake in the CR group was not significantly different from baseline (P = 0.10). The interaction between group and time for the DLW-based estimates of energy intake was significant (P = 0.01) after baseline energy intake was accounted for.

According to the 7-d food records, calorie intake in the EX and HL groups was not significantly different from baseline during the intervention. Energy intake in the CR group was lower than baseline at all time points during the intervention (Figure 2). The interaction between group and time for the food record–based estimates of energy intake was significant (P = 0.003) after baseline energy intake was accounted for.

Body weight and composition
Total body weight, BMI, total fat mass, truncal fat mass, and abdominal fat mass all decreased in the EX and CR groups but remained unchanged in the HL group (Table 2). As a result, the final values for weight and all of the body-composition measures were lower in the EX and CR groups than in the HL group after adjustment for baseline values. Body weight did not change during the 3 wk before the final OGTT in either the EX group (3 wk before the OGTT: 70.4 ± 9.6 kg; day of the OGTT: 69.8 ± 9.0 kg) or the CR group (3 wk before the OGTT: 70.7 ± 11.0 kg; day of the OGTT: 70.8 ± 11.0 kg).


View this table:
TABLE 2. Body weight and body composition before and after the intervention1

 
Body weight, total fat mass, energy intake, aerobic capacity, and physical activity data are included as indicators of compliance and to help in the interpretation of results for the primary outcomes. These outcomes were also published elsewhere (19).

Insulin action and OGTT insulin concentrations
ISI increased in the exercise and CR groups but not in the HL group. As a result, and after adjustment for baseline values, ISI was greater in the EX and CR groups than in the HL group at the end of the intervention (Table 3). The final adjusted ISI means were not different between the exercise and CR groups. Likewise, fasting insulin and insulin AUC decreased in the EX and CR groups but not in the HL group, such that the final adjusted values were significantly lower in the EX and CR groups than in the HL group. Because of baseline differences in ISI, we evaluated the OGTT insulin data after adjusting for baseline ISI; however, this did not change the statistical significance of the findings for OGTT insulin.


View this table:
TABLE 3. Indexes of glucose tolerance and insulin action before and after the intervention1

 
Oral glucose tolerance
Although fasting glucose decreased in the CR group but not in the EX or HL group, the final fasting glucose values were not significantly different between the groups after adjustment for baseline values (Table 3), and these results were unaffected after baseline ISI was included as a covariate. Final glucose AUC values were not significantly different between study groups after adjustment for baseline values. However, after baseline ISI was added as a covariate, the P value of 0.11 for glucose AUC (Table 3) became significant (P = 0.03) and there were significant differences between both intervention groups and the control group.

Adiponectin, TNF-, cortisol, and FFA
Serum adiponectin concentration tended to increase in the exercise (P = 0.06) and the CR (P = 0.07) groups and decreased significantly in the HL group (P = 0.05) (Table 4). At the end of the intervention, adiponectin concentrations were higher in the EX and CR groups than in the HL group but were not significantly different between the EX and CR groups. Final adjusted serum TNF- concentrations were not significantly different between study groups. The ratio of TNF- to adiponectin tended to decrease in the EX group (P = 0.06), decreased significantly in the CR group, but remained unchanged in the HL group. As a result, the final adjusted ratios of TNF- to adiponectin were significantly lower in the EX and CR groups than in the HL group. Final ratios of TNF- to adiponectin were not significantly different between the EX and CR groups. Final serum cortisol concentrations, after adjustment for baseline values, did not differ significantly between the 3 study groups. Serum FFAs did not change significantly in any of the study groups, and the final adjusted values were not significantly different between groups. None of the statistical results for the outcomes reported in Table 4 were affected by the inclusion of baseline ISI as a covariate.


View this table:
TABLE 4. Circulating serum adiponectin, tumor necrosis factor (TNF-), cortisol, and free fatty acid (FFA) concentrations before and after the intervention1

 
To gain insight into the mechanism of improvements in ISI that resulted from exercise and calorie restriction, the correlations between changes in ISI, after accounting for the effects of baseline ISI, and the changes in adiponectin, TNF-, and the ratio of TNF- to adiponectin, were assessed. No significant difference (P = 0.37) was evident between the EX and CR groups with respect to the correlations between change in adiponectin and the change in ISI (EX group: r = 0.47; CR group: r = 0.17). Likewise, the correlations for change in TNF- and change in ISI were not significantly different (P = 0.06) between groups (EX group: r = –0.34; CR group: r = 0.33). In contrast, the correlation between the change in the ratio of TNF- to adiponectin and the change in ISI was stronger in the EX group (r = –0.67, P = 0.005) than in the CR group (r = 0.005, P = 0.98); P = 0.03 for the comparison between the EX and CR groups (Figure 3).


View larger version (14K):
FIGURE 3.. Relations between changes in the ratio of tumor necrosis factor (TNF-) and adiponectin concentrations and changes in the insulin sensitivity index (ISI) in the exercise training (EX) group (n = 17; 1 subject was excluded because of technical problems during data collection) and the calorie restriction (CR) group (n = 18). Raw data were used for presentation; however, the associations were assessed by using Pearson’s correlations after the effects of baseline ISI were accounted for. The correlation in the EX group was significantly greater than that in the CR group, P = 0.03 (Fisher’s z transformation).

 

DISCUSSION  
The main finding of the present study was that weight losses achieved by 12 mo of exercise training with no change in food intake and 12 mo of calorie restriction resulted in significant improvements in glucose tolerance and insulin action that were not significantly different between groups. Furthermore, these 2 interventions resulted in marginally significant improvements in circulating adiponectin concentrations and in the ratio of TNF- to adiponectin.

The only other direct comparisons of exercise training–and calorie restriction–induced weight loss on improvements in insulin action are those of Ross et al (8, 9), who reported enhancements in insulin action in response to exercise training–induced weight loss and calorie restriction–induced weight loss that were not significantly different between groups. Most of the participants in the studies by Ross et al were obese at baseline and were still overweight or obese after the intervention. In contrast, the subjects in the present study were, on average, overweight (BMI: 27.1 ± 1.9)—none were obese—and the weight losses normalized body weight (BMI < 25.0) in 52% of the overweight participants in the exercise and calorically restricted groups. Whereas Ross et al’s interventions lasted 12–14 wk, we used a more gradual 1-y intervention to reduce body weight. Despite the differences in baseline body weight and the duration and intensity of the interventions between these studies, the findings of the present study agree with those of Ross et al (8, 9).

There are several possible explanations for why exercise training–induced weight loss did not result in greater improvements in insulin action than did calorie restriction, as we had hypothesized. One possibility is that the main factor responsible for the improvements was the decrease in body fat, particularly abdominal fat, which was not significantly different between the 2 groups. Another possibility is that the weight loss–independent benefits of exercise training on insulin action might have worn off before the final OGTT, because these effects are lost rapidly (20, 21). The participants in the EX group were asked to refrain from exercise for 48 h before the final OGTT, and the median amount of time between the last exercise bout and the OGTT was 58 h. In this time frame, it is unlikely that the exercise training effects would have worn off because studies in humans have shown that the myocellular adaptations associated with enhanced glucose uptake in trained muscle are still evident when measured 48–72 h after the cessation of exercise (22-24). Furthermore, it has been reported that glucose tolerance and insulin action do not deteriorate within 3 d of detraining in moderately trained middle-aged men and women (20).

Another possible explanation for why improvements in glucose tolerance and insulin action were not greater in the EX group than in the CR group was that the exercise training–induced improvement in insulin action might have been matched by a calorie restriction–specific effect that improved insulin sensitivity. One such mechanism could be a calorie restriction–specific skeletal muscle adaptation, because it has been shown, in rats, that calorie restriction augments insulin-stimulated glucose transport (25) through a mechanism that may be distinct from the exercise training–specific mechanism (26). If exercise training and calorie restriction increase insulin action through distinct mechanisms, the combination of calorie restriction and exercise training should result in greater improvements in insulin action than will weight loss by either intervention alone. Indeed, results from most (6, 7, 27, 28), but not all (29, 30), studies that compared the effects of calorie restriction with those of calorie restriction and exercise training combined, suggest that the effects of calorie restriction and exercise training are additive.

Both exercise training–and calorie restriction–induced weight loss resulted in modestly higher serum adiponectin concentrations than did the healthy lifestyle intervention. Although adiponectin concentrations have been shown to increase after weight loss induced by medication use (31) or by gastrointestinal bypass surgery (32), weight loss induced by diet or exercise training has generally not been shown to alter adiponectin concentration (33-36). A likely explanation for this discrepancy is that the other investigators studied obese individuals, whereas most of our participants were overweight and none were obese (BMI < 30). On the basis of cross-sectional data, adiponectin concentrations are associated with BMI but only when BMI is below 29 (37). It seems reasonable, therefore, that changes in BMI lead to changes in adiponectin concentrations, but only with weight losses that result in BMIs < 29. The inflammatory cytokine TNF- has been shown to decrease insulin action (38, 39). In the present study, circulating TNF- did not differ significantly in response to the different interventions. However, in light of recent evidence, which suggests that TNF- and adiponectin may be reciprocally regulated (40-42), we assessed the effects of our interventions on the ratio of TNF- to adiponectin. Both exercise training and calorie restriction resulted in lower ratios by the end of the study.

Although changes in the ratio of TNF- to adiponectin were not significantly different between the EX and CR groups, these changes only correlated with the changes in insulin action in the EX group (Figure 3). This finding suggests that the changes in these cytokines are a more important mechanism for the improvement in insulin action in response to exercise training–induced weight loss than for that in response to calorie restriction. This is evidence, albeit preliminary, that some of the mechanisms are distinct for the improvements in insulin action that result from exercise training–induced weight loss compared with those that result from calorie restriction–induced weight loss.

Two methods were used to measure energy intake in the present study. To some extent, the energy intake estimates from these methods conflict with each other in the CR group (Figure 2). According to the DLW method, energy intake in the CR group was 340 kcal/d below baseline during the first 6 mo of the intervention but only 128 kcal/d below baseline and not significantly different from baseline (P = 0.10) during the last 3 mo of the intervention. In contrast, food record–based estimates of energy intake for the CR group indicate that energy intake was 300 kcal/d below baseline throughout the intervention. In light of the difficulties of using DLW to estimate energy intake during weight loss and considering the well-known limitations of food record–based estimates of energy intake, it is difficult to know which of these estimates of change in energy intake is more accurate. It is important to note, however, that body weight and body fat mass decreased substantially in the CR group (Table 2) and remained remarkably stable during the last 3 wk of the intervention. In the absence of increases in physical activity levels, as evidenced by the PAR data (Figure 2) and a lack of increase in absolute O2max (Table 1), it is likely that energy intake was below baseline and stable at the end of the intervention as evidenced by the absence of weight gain.

The results of this trial have clinical ramifications, especially in light of the growing epidemic of type 2 diabetes. Although diet and exercise training can greatly reduce the incidence of type 2 diabetes (43, 44), the relative contributions of exercise training and calorie restriction to these protective effects are not known. Data from the present study suggest that weight loss induced by exercise training and by calorie restriction are not different with respect to their abilities to improve glucose tolerance and insulin action and, presumably, to lower the risk of type 2 diabetes.

In summary, data from the present study suggest that exercise training–and calorie restriction–induced weight loss are effective means for improving glucose tolerance and insulin action in nonobese, healthy, middle-aged men and women. It does not appear that exercise training–induced weight loss provides benefits above and beyond those that can be achieved by calorie restriction alone if exercise training is discontinued for 2 d.


ACKNOWLEDGMENTS  
We are grateful to the study participants for their cooperation and to the staff of the Applied Physiology Laboratory and Nurses of the General Clinical Research Center at Washington University School of Medicine for their skilled assistance.

JOH and SK designed the study. EPW, SBR, DTV, LF, KS-M, and JOH collected the data and supervised its collection. EPW, SBR, DTV, KS-M, KBS, and JOH analyzed and interpreted the data. EPW, SBR, KS-M, SK, and JOH wrote the manuscript. None of the authors had a conflict of interest.


REFERENCES  

  1. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care2003; 26 :1706 –13.
  2. Mykkanen L, Laakso M, Pyorala K. Association of obesity and distribution of obesity with glucose tolerance and cardiovascular risk factors in the elderly. Int J Obes Relat Metab Disord1992; 16 :695 –704.
  3. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol2002; 40 :937 –43.
  4. Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol2005; 99 :338 –43.
  5. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA1995; 274 :1915 –21.
  6. Dengel DR, Galecki AT, Hagberg JM, Pratley RE. The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. Am J Hypertens1998; 11 :1405 –12.
  7. Dengel DR, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol1996; 81 :318 –25.
  8. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med2000; 133 :92 –103.
  9. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res2004; 12 :789 –98.
  10. Racette SB, Weiss EP, Obert KA, Kohrt WM, Holloszy JO. Modest lifestyle intervention and glucose tolerance in obese African Americans. Obes Res2001; 9 :348 –55.
  11. Morgan DR, Lazarow A. Immunoassay of insulin: two antibody system. Diabetes1963; 12 :115 –26.
  12. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care1995; 18 :245 –50.
  13. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care1999; 22 :1462 –70.
  14. DeLany JP, Schoeller DA, Hoyt RW, Askew EW, Sharp MA. Field use of D2 18O to measure energy expenditure of soldiers at different energy intakes. J Appl Physiol1989; 67 :1922 –9.
  15. Schoeller DA. Measurement of energy expenditure in free-living humans by using doubly labeled water. J Nutr1988; 118 :1278 –89.
  16. Kohrt WM, Malley MT, Coggan AR, et al. Effects of gender, age, and fitness level on response of VO2max to training in 60–71 yr olds. J Appl Physiol1991; 71 :2004 –11.
  17. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol1985; 121 :91 –106.
  18. Sallis JF. Seven-day physical activity recall. Med Sci Sports Exerc1997; 29 (suppl):S89 –103.
  19. Racette SB, Weiss EP, Villareal DT, et al. One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci2006; 61 :943 –50.
  20. King DS, Baldus PJ, Sharp RL, Kesl LD, Feltmeyer TL, Riddle MS. Time course for exercise-induced alterations in insulin action and glucose tolerance in middle-aged people. J Appl Physiol1995; 78 :17 –22.
  21. Oshida Y, Yamanouchi K, Hayamizu S, Nagasawa J, Ohsawa I, Sato Y. Effects of training and training cessation on insulin action. Int J Sports Med1991; 12 :484 –6.
  22. Ebeling P, Bourey R, Koranyi L, et al. Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest1993; 92 :1623 –31.
  23. Yu M, Blomstrand E, Chibalin AV, Wallberg-Henriksson H, Zierath JR, Krook A. Exercise-associated differences in an array of proteins involved in signal transduction and glucose transport. J Appl Physiol2001; 90 :29 –34.
  24. Hughes VA, Fiatarone MA, Fielding RA, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol1993; 264 :E855 –62.
  25. Cartee GD, Kietzke EW, Briggs-Tung C. Adaptation of muscle glucose transport with caloric restriction in adult, middle-aged, and old rats. Am J Physiol1994; 266 :R1443 –7.
  26. Dean DJ, Brozinick JT Jr, Cushman SW, Cartee GD. Calorie restriction increases cell surface GLUT-4 in insulin-stimulated skeletal muscle. Am J Physiol1998; 275 :E957 –64.
  27. Rice B, Janssen I, Hudson R, Ross R. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care1999; 22 :684 –91.
  28. Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB. Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr2004; 80 :308 –16.
  29. Janssen I, Fortier A, Hudson R, Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care2002; 25 :431 –8.
  30. Weinstock RS, Dai H, Wadden TA. Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance. Arch Intern Med1998; 158 :2477 –83.
  31. Valsamakis G, McTernan PG, Chetty R, et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism2004; 53 :430 –4.
  32. Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg2005; 15 :692 –9.
  33. Manigrasso MR, Ferroni P, Santilli F, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab2005; 90 :5876 –9.
  34. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord2003; 27 :1066 –71.
  35. Giannopoulou I, Fernhall B, Carhart R, et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism2005; 54 :866 –75.
  36. Xydakis AM, Case CC, Jones PH, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab2004; 89 :2697 –703.
  37. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun1999; 257 :79 –83.
  38. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor- induces skeletal muscle insulin resistance in healthy human subjects via inhibition of akt substrate 160 phosphorylation. Diabetes2005; 54 :2939 –45.
  39. Lechleitner M, Herold M, Dzien-Bischinger C, Hoppichler F, Dzien A. Tumour necrosis factor-alpha plasma levels in elderly patients with type 2 diabetes mellitus—observations over 2 years. Diabet Med2002; 19 :949 –53.
  40. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab2003; 285 :E527 –33.
  41. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med2002; 8 :731 –7.
  42. Behre CJ, Fagerberg B, Hulten LM, Hulthe J. The reciprocal association of adipocytokines with insulin resistance and C-reactive protein in clinically healthy men. Metabolism2005; 54 :439 –44.
  43. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med2001; 344 :1343 –50.
  44. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med2002; 346 :393 –403.
Received for publication January 27, 2006. Accepted for publication June 15, 2006.


作者: Edward P Weiss
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具